Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001651308-21-000189
Filing Date
2021-09-02
Accepted
2021-09-02 20:40:28
Documents
1
Period of Report
2021-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163062961139885.html 4  
1 FORM 4 wf-form4_163062961139885.xml 4 55374
  Complete submission text file 0001651308-21-000189.txt   56818
Mailing Address C/O GENTA INC 3550 GENERAL ATOMICS CT BLDG 9 SAN DIEGO CA 92121
Business Address
OYLER JOHN (Reporting) CIK: 0001042047 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37686 | Film No.: 211234905

Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Issuer) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations